Lill Trogstad
Overview
Explore the profile of Lill Trogstad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ollila H, Fonseca-Rodriguez O, Caspersen I, Kalucza S, Normark J, Trogstad L, et al.
BMJ Public Health
. 2025 Feb;
2(1):e000336.
PMID: 40018228
Introduction: SARS-CoV-2 infection causes acute COVID-19 and may result in post-COVID syndrome (PCS). We aimed to investigate how clinicians diagnose PCS and identify associated clinical and demographic characteristics. Methods: We...
2.
Ro G, Lyngstad T, Seppala E, Naerland Skodvin S, Trogstad L, White R, et al.
PLoS One
. 2025 Jan;
20(1):e0317105.
PMID: 39883654
Estimating the trend of new infections was crucial for monitoring risk and for evaluating strategies and interventions during the COVID-19 pandemic. The pandemic revealed the utility of new data sources...
3.
Gehrt L, Vahlkvist S, Houmann Petersen T, Englund H, Nieminen H, Laake I, et al.
Acta Paediatr
. 2025 Jan;
PMID: 39803879
Aim: Estimate the incidence of asthma among children aged 0 to 15 years in Denmark, Finland, Norway and Sweden during 2000-2017. Methods: Cases of preschool asthma (up to 6 years)...
4.
Gehrt L, Moller S, Englund H, Laake I, Nieminen H, Feiring B, et al.
J Infect
. 2025 Jan;
90(2):106365.
PMID: 39788159
Objectives: To investigate if receipt of measles-mumps-rubella (MMR) vaccine following the third dose of diphtheria-tetanus-acellular pertussis (DTaP3) is associated with reduced rates of non-targeted infectious disease hospitalisations. Methods: Register based...
5.
Caspersen I, Skodvin S, Blix K, Robertson A, Laake I, Feiring B, et al.
Vaccine
. 2025 Jan;
47:126664.
PMID: 39787799
Background: The impact of vaccination on the type and risk of specific post-COVID symptoms after Omicron infection is not clear. We aimed to investigate the excess risk and patterns of...
6.
Laake I, Feiring B, Gehrt L, Englund H, Lahdenkari M, Sorup S, et al.
Eur J Epidemiol
. 2025 Jan;
40(1):81-93.
PMID: 39760962
It has been suggested that non-live vaccines may increase susceptibility to non-targeted infections and that such deleterious non-specific effects are more pronounced in girls. We investigated whether receipt of non-live...
7.
Mukherjee R, Eggesbo L, Wolf A, Kjonstad I, Solum G, Ravussin A, et al.
NPJ Vaccines
. 2024 Nov;
9(1):238.
PMID: 39613759
Heterogeneity in vaccine response, particularly in vulnerable populations like the elderly, represents a significant public health challenge. We conducted an in-depth examination of immune cell profiles before and after SARS-CoV-2...
8.
Allotey J, Archer L, Snell K, Coomar D, Masse J, Sletner L, et al.
BMJ Med
. 2024 Aug;
3(1):e000784.
PMID: 39184566
Objective: To predict birth weight at various potential gestational ages of delivery based on data routinely available at the first antenatal visit. Design: Individual participant data meta-analysis. Data Sources: Individual...
9.
Tunheim G, Fossum E, Robertson A, Ro G, Chopra A, Vaage J, et al.
BMC Infect Dis
. 2024 Aug;
24(1):841.
PMID: 39164637
Background: According to Norwegian registries, 91% of individuals ≥ 16 years had received ≥ 1 dose of COVID-19 vaccine by mid-July 2022, whereas less than 2% of children < 12...
10.
Gehrt L, Englund H, Laake I, Nieminen H, Moller S, Feiring B, et al.
Vaccine
. 2024 Mar;
42(12):2955-2965.
PMID: 38508926
Objectives: Previous studies have shown that vaccination against measles, mumps, and rubella (MMR) may have beneficial non-specific effects, reducing the risk of infections not targeted by the vaccine. We investigated...